Effect of juglans regial on diabetes

Phase 3

• Conditions: Condition 1: Diabetes. Condition 2: Disorder of lipoprotein metabolism.; Non-insulin-dependent diabetes mellitus; Disorder of lipoprotein metabolism, unspecified

• Registration Number: IRCT201106076720N1
• Lead Sponsor: Jahad Daneshgahii

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 22 February 2018

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 61

Inclusion Criteria

age between 40 to 60 years; confirmed type II diabetes at least for two years with fasting blood glucose 150-250 mg/dl; taking metformin or glibencalamid; having HbA1c 7.5-10%; All patients singed the written informed consent. Exclusion criteria: insulin therap; infectious diseases; severe kidney disease with Cr>270 umol/L; liver, heart or pulmonary disease; hypersensitivity to any drug; foot ulcer or gangrene; major depressive disorders; active cancer or previous cancer during the last 5 years; alcohol consumption; cigarette smoking; pregnancy and breast feeding.

Exclusion Criteria

Not provided

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Glycosylated hemoglobin. Timepoint: Baseline and after three months. Method of measurement: HPLC method.;TG - total cholesterole. Timepoint: Baseline and after three months. Method of measurement: Fasting blood Cholesterol and TG level in Baseline and after three months by enzymatic oxidase method.;Fasting blood glucose. Timepoint: Baseline and after three months. Method of measurement: Glucose oxidase method.

Secondary Outcome Measures

Name	Time	Method
SGOT. Timepoint: Baseline and after three months. Method of measurement: SGOT level in fasting blood sample by DGKG enzymatic method.;SGPT. Timepoint: Baseline and after three months. Method of measurement: SGPT level in fasting blood sample by DGKG enzymatic method.;Creatinin. Timepoint: Baseline and after three months. Method of measurement: The fasting blood Creatinin level by JAPH enzymatic method.